Global Drug Abuse Treatment Market Overview
Drug abuse can be defined as a disorder in which an individual get totally addicted to certain type of substance such as heroin, cocaine, cigarettes, tobacco, marijuana etc. Drug abuse is a treatable condition and can be treated with certain type of medication which has been approved by various regulatory bodies around the world.
High prevalence of drug abuse in key regions is expected to significantly increase demand for drug abuse treatment drugs and fuel its market growth over forecast period of time. For instance, as per National Institute on Alcohol Abuse and Alcoholism, in U.S. around 15.1 million adults ages 18 and older which constitute around 6.2% of this age group are suffering from Alcohol use disorder (AUD), this includes 9.8 million men and 5.3 million women.
Launches and approval of novel drugs for the treatment of different type of drugs abuse practices is expected to cater the market growth over the forecast period of time. For instance, in June 2018, Dr. Reddy\'s Laboratories, an Indian pharmaceutical giant received U.S. Food and Drug Administration approval to launch its generic version of Indivior Plc’s Suboxone Sublingual Film indicated for the treatment of adults with opioid addiction.
The drug abuse treatment market has been segmented on the basis of abuse type, drug type, distribution channel, and region.
On the basis of abuse type, the drug abuse treatment market has been segmented in opioid addiction, alcohol dependence, tobacco/ nicotine addiction, and others.
On the basis of drug typethe drug abuse treatment market has been segmented indisulfiram, acamprosate, bupropion, varenicline, naltrexone, buprenorphine, nicotine replacement treatment (nicotine patch, nicotine gum, nicotine lozenge, nicotine spray, and nicotine inhaler) and others.
On the basis of distribution channel, the drug abuse treatment market has been segmented in retail pharmacies, online pharmacies, hospitals, and others.
On the basis of region, the target market has been segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is expected to account major market share as compared to that of other regions.
Key players operating in the drug abuse treatment market includes, Pfizer Inc., Mylan N.V., Cipla Limited, Odyssey Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals, Lil\' Drug Store Products Inc., Dr. Reddy\'s Laboratories, Indivior Plc., and British American Tobacco Plc.
Global Drug Abuse Treatment Market Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Preview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Abuse Type
- Market Snippet, By Drug Type
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Opportunity Map Analysis
- Report Description
- Market Dynamics Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- Drivers- Restraints Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Market Dynamics
- Market Segmentation, By Abuse Type, 2018 – 2028, (US$ Mn)
- Introduction
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
- Y-o-Y Growth Analysis (%), 2019 – 2028
- Segment Trends
- Opioid Addiction
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Alcohol Dependence
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Tobacco/Nicotine Addiction
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Others
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Introduction
- Market Segmentation, By Drug Type, 2018 – 2028, (US$ Mn)
- Introduction
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
- Y-o-Y Growth Analysis (%), 2019 – 2028
- Segment Trends
- Disulfiram
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Acamprosate
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Bupropion
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Varenicline
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Naltrexone
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Buprenorphine
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Nicotine Replacement Treatment
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Introduction
Ø Nicotine Patch
Ø Nicotine Gum
Ø Nicotine Lozenge
Ø Nicotine Spray
Ø Nicotine Inhaler
- Others
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Market Segmentation, By Distribution Channel, 2018 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis (%), 2019 – 2028
- Segment Trends
- Retail Pharmacy
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Online Pharmacy
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Hospital Pharmacy
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Others
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Introduction
- Global Market, By Region, 2018 – 2028, (US$ Mn)
- Introduction
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
- Y-o-Y Growth Analysis (%), 2019 – 2028
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Abuse Type, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Drug Type, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Distribution Channel, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2028
- Introduction
Ø U.S.
Ø Canada
- Latin America
- Market Size and Forecast (US$ Mn), By Abuse Type, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Drug Type, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Distribution Channel, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2028
Ø Brazil
Ø Mexico
Ø Argentina and Chile
Ø Rest of Latin America
- Europe
- Market Size and Forecast (US$ Mn), By Abuse Type, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Drug Type, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Distribution Channel, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2028
Ø Germany
Ø UK
Ø France
Ø Russia
Ø Italy
Ø Switzerland
Ø Sweden
Ø Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Abuse Type, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Drug Type, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Distribution Channel, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2028
Ø China
Ø India
Ø Australia & New Zealand
Ø Japan
Ø South Korea
Ø Rest of Asia Pacific
- Middle East
- Market Size and Forecast (US$ Mn), By Abuse Type, 2018 – 2028
- \Market Size and Forecast (US$ Mn), By Drug Type, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Distribution Channel, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2028
Ø GCC
Ø Israel
Ø Saudi Arabia
Ø UAE
Ø Rest of Middle East
- Africa
- Market Size and Forecast (US$ Mn), By Abuse Type, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Drug Type, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Distribution Channel, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2028
Ø North Africa
Ø Central Africa
Ø South Africa
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Pfizer Inc.
Ø Company Overview
Ø Product Portfolio
Ø Key Highlights
Ø Financial Overview
Ø Business Strategy Overview
- Mylan N.V.
Ø Company Overview
Ø Product Portfolio
Ø Key Highlights
Ø Financial Overview
Ø Business Strategy Overview
- Cipla Limited
Ø Company Overview
Ø Product Portfolio
Ø Key Highlights
Ø Financial Overview
Ø Business Strategy Overview
§ Odyssey Pharmaceuticals Inc.
Ø Company Overview
Ø Product Portfolio
Ø Key Highlights
Ø Financial Overview
Ø Business Strategy Overview
- Teva Pharmaceutical Industries Ltd.
Ø Company Overview
Ø Product Portfolio
Ø Key Highlights
Ø Financial Overview
Ø Business Strategy Overview
- Glenmark Pharmaceuticals
Ø Company Overview
Ø Product Portfolio
Ø Key Highlights
Ø Financial Overview
Ø Business Strategy Overview
- Lil\' Drug Store Products Inc.
Ø Company Overview
Ø Product Portfolio
Ø Key Highlights
Ø Financial Overview
Ø Business Strategy Overview
- Dr. Reddy\'s Laboratories
Ø Company Overview
Ø Product Portfolio
Ø Key Highlights
Ø Financial Overview
Ø Business Strategy Overview
- Indivior Plc.
Ø Company Overview
Ø Product Portfolio
Ø Key Highlights
Ø Financial Overview
Ø Business Strategy Overview
- British American Tobacco Plc.
Ø Company Overview
Ø Product Portfolio
Ø Key Highlights
Ø Financial Overview
Ø Business Strategy Overview
- Analyst Views
- Section
- Research Methodology
- About Us
- Contact
FAQs
The drug abuse treatment market has been segmented on the basis of abuse type, drug type, distribution channel, and region.
Key players operating in the drug abuse treatment market includes, Pfizer Inc., Mylan N.V., Cipla Limited, Odyssey Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals, Lil\' Drug Store Products Inc., Dr. Reddy\'s Laboratories, Indivior Plc., and British American Tobacco Plc.
High cost of drug might hamper the market.
High prevalence of drug abuse in key regions is expected to significantly increase demand for drug abuse treatment drugs and fuel its market growth over forecast period of time.
North America is expected to account major market share as compared to that of other regions.